Abstract
Purpose
Small choroidal melanocytic lesions have a low rate of metastasis and can be reasonably managed with surveillance until they demonstrate evidence of growth or clinical risk factors for melanoma. However, even choroidal nevi are not stationary, with many exhibiting slow growth over time. We sought to quantify the growth rates of indeterminate choroidal lesions that were initially observed prior to a clinical diagnosis of melanoma.
Methods
A single-center retrospective study was performed of patients diagnosed with choroidal melanoma based upon clinical characteristics who were initially followed for indeterminate lesions over at least 6 months. Subjects were included if they had a minimum of two B-scan ultrasound measurements prior to the visit at which melanoma was diagnosed. Demographic and tumor characteristics were collected from the medical record. Growth rates were calculated as the change in lesion thickness in mm per month and were recorded at 6-month intervals; ultrasound measurements less than 1 month apart were excluded. The characteristics of indeterminate lesions with faster versus slower growth rates prior to melanoma diagnosis were compared.
Results
Fifty-four patients met inclusion criteria. The mean age at melanoma diagnosis was 67.4 years, and 53.7% were female. Subjects had a median of four B-scan ultrasound measurements prior to melanoma diagnosis (range 2–19) and were followed for a median of 40.6 months (range 9.9–138.0 months). The mean lesion thickness was 1.4 mm (range 0.5–2.2 mm) at presentation, and increased to 2.3 mm (range 1.5–5.7 mm) at melanoma diagnosis. The mean growth rate did not exceed 0.021 mm/month (95% CI: 0.004–0.039; equivalent to 0.25 mm/year) for indeterminate lesions, but increased to 0.057 mm/month (95% CI: 0.043–0.071 mm/month; equivalent to 0.68 mm/year) at the time of melanoma diagnosis. Rapidly growing lesions had a greater tumor thickness and shorter duration of observation at the time of melanoma diagnosis.
Conclusion
For most indeterminate choroidal lesions eventually diagnosed as melanoma, the lesion thickness was relatively stable for a period of time, then rose significantly between the penultimate visit and the final visit. These findings confirm the recommendation for continued monitoring of suspicious choroidal lesions, as the growth rate may accelerate just prior to melanoma diagnosis. Lesions with a mean growth rate of up to 0.25 mm/year were observed, whereas lesions clinically determined to have transformed into melanoma demonstrated a mean growth rate of 0.68 mm/year. These values provide a baseline for future studies and potential therapies directed at stabilizing or reducing the growth of indeterminate choroidal lesions or small choroidal melanomas. Limitations of this study include its retrospective nature and reliance on clinical diagnostic criteria.
Similar content being viewed by others
References
Murray TG, Sobrin L (2006) The case for observational management of suspected small choroidal melanoma. Arch Ophthalmol Chic Ill 1960 124(9):1342–1344
Shields JA (2006) Treating some small melanocytic choroidal lesions without waiting for growth. Arch Ophthalmol Chic Ill 1960 124(9):1344–1346
Gass JD (1985) Comparison of uveal melanoma growth rates with mitotic index and mortality. Arch Ophthalmol Chic Ill 1960 103(7):924–931
(1997) Mortality in patients with small choroidal melanoma. COMS report no. 4. The Collaborative Ocular Melanoma Study Group. Arch Ophthalmol 115(7):886–93
Jouhi S, Jager MJ, de Geus SJR et al (2019) The small fatal choroidal melanoma study. A survey by the European Ophthalmic Oncology Group. Am J Ophthalmol 202:100–108
Lane AM, Egan KM, Kim IK, Gragoudas ES (2010) Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol Chic Ill 1960 128(8):996–1000
Augsburger JJ, Schroeder RP, Territo C et al (1989) Clinical parameters predictive of enlargement of melanocytic choroidal lesions. Br J Ophthalmol 73(11):911–917
(1997) Factors predictive of growth and treatment of small choroidal melanoma: COMS Report No. 5. The Collaborative Ocular Melanoma Study Group. Arch Ophthalmol 115(12):1537–44. https://doi.org/10.1001/archopht.1997.01100160707007
Butler P, Char DH, Zarbin M, Kroll S (1994) Natural history of indeterminate pigmented choroidal tumors. Ophthalmology 101(4):710–716; discussion 717. https://doi.org/10.1016/s0161-6420(94)31274-7
Sobrin L, Schiffman JC, Markoe AM, Murray TG (2005) Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study. Ophthalmology 112(10):1777–1783
Shields CL, Dalvin LA, Yu MD et al (2019) Choroidal nevus transformation into melanoma per millimeter increment in thickness using multimodal imaging in 2355 cases: the 2019 Wendell L. Hughes Lecture. Retina Phila Pa 39(10):1852–1860
Elner VM, Flint A, Vine AK (2004) Histopathology of documented growth in small melanocytic choroidal tumors. Arch Ophthalmol Chic Ill 1960 122(12):1876–1878
Mruthyunjaya P, Schefler AC, Kim IK et al (2020) A phase 1b/2 open-label clinical trial to evaluate the safety and efficacy of AU-011 for the treatment of choroidal melanoma. Invest Ophthalmol Vis Sci 61(7):4025–4025
Goitein M, Miller T (1983) Planning proton therapy of the eye. Med Phys 10(3):275–283
Shields CL, Dalvin LA, Ancona-Lezama D et al (2019) Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 Taylor R. Smith and Victor T. Curtin Lecture. Retina Phila Pa 39(10):1840–1851
Mashayekhi A, Siu S, Shields CL, Shields JA (2011) Slow enlargement of choroidal nevi: a long-term follow-up study. Ophthalmology 118(2):382–388
Raval V, Luo S, Zabor EC, Singh AD (2021) Small choroidal melanoma: correlation of growth rate with pathology. Ocul Oncol Pathol 7(6):401–410
Augsburger JJ, Gonder JR, Amsel J et al (1984) Growth rates and doubling times of posterior uveal melanomas. Ophthalmology 91(12):1709–1715
Char DH, Heilbron DC, Juster RP, Stone RD (1983) Choroidal melanoma growth patterns. Br J Ophthalmol 67(9):575–578
Char DH, Kroll S, Phillips TL (1997) Uveal melanoma. Growth rate and prognosis. Arch Ophthalmol Chic Ill 1960 115(8):1014–1018
Friberg TR, Fineberg E, McQuaig S (1983) Extremely rapid growth of a primary choroidal melanoma. Arch Ophthalmol Chic Ill 1960 101(9):1375–1377
Shields CL, Sioufi K, Srinivasan A et al (2018) Visual outcome and millimeter incremental risk of metastasis in 1780 patients with small choroidal melanoma managed by plaque radiotherapy. JAMA Ophthalmol 136(12):1325–1333
Kines RC, Varsavsky I, Choudhary S et al (2018) An infrared dye-conjugated virus-like particle for the treatment of primary uveal melanoma. Mol Cancer Ther 17(2):565–574
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of the Massachusetts General Brigham.
Informed consent
Informed consent was obtained from all individual participants included in the study, except when deemed exempt by the Institutional Review Board.
Conflict of interest
Dr. Kim receives research support as a clinical trial investigator for Aura Biosciences. Dr. Gragoudas is a consultant for Aura Biosciences.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wu, F., Lane, A.M., Oxenreiter, M.M. et al. Growth rate of indeterminate choroidal lesions prior to melanoma diagnosis. Graefes Arch Clin Exp Ophthalmol 261, 3635–3641 (2023). https://doi.org/10.1007/s00417-023-06130-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-023-06130-0